Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 141-150

  Joshi, Sunil K ^a   Bharadwaj, Ashima ^a   Chatterjee, Shyama ^b   Chauhan, V S ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; LIVER STAGE ANTIGEN 1; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE CONSTRUCT; HUMAN; IMMUNOGENICITY; INDIA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; PARASITE IMMUNITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE;

EID: 0033985760     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.141-150.2000     Document Type: Article

References (43)

1. Akhiani, A. A., L. A. Nilsson, and O. Ouchterlony. 1997. Immunological cross-reactivity between Schistosoma mansoni and cholera toxin. Parasite Immunol. (Oxford) 19:355-361.
2. Atkinson, C. T., M. R. Hollingdale, and M. Aikawa. 1992. Localization of a 230 kDa parasitophorous vacuole membrane antigen of Plasmodium berghci exoerythrocytic schizonts (LSA-2) by immunoelectron and confocal laser scanning microscopy. Am. J. Trop. Med. Hyg. 46:533-537.
3. Bharadwaj, A., P. Sharma, S. K. Joshi, B. Singh, and V. S. Chauhan. 1998. Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigens. Infect. Immun. 66:3232-3241.
4. Bottius, E., L. BenMohammed, K. Brahimi, H. Gras, J. P. Lepers, L. Raharimalala, M. Aikawa, J. Meis, B. Slierendregt, A. Sartan, A. Thomas, and P. Druilhe. 1996. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J. Immunol. 156:2874-2884.
5. Calvo-Calle, J. M., J. Hammer, F. Sinigaglia, P. Clavijo, Z. R. Moya-Castro, and E. H. Nardin. 1997. Binding of malaria T cell epitopes to DR and DO molecules in vitro correlates with immunogenicity in vivo. J. Immunol. 159: 1362-1373.
6. Chatterjee, S., G. Francois, P. Druilhe, G. Timperman, and M. Wery. 1996. Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites. Parasitol. Res. 82:297-303.
7. Chatterjee, S., P. Sharma, S. Kumar, and V. S. Chauhan. 1995. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens. Vaccine 13:1474-1481.
8. Chatterjee, S., M. Wery, P. Sharma, and V. S. Chauhan. 1995. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge. Infect. Immun. 63:4375-4381.
9. Chauhan, V. S., S. Chatterjee, and P. K. Johar. 1993. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria. Parasite Immunol. (Oxford) 15:239-242.
10. Clyde, D. F., V. C. McCarthy, R. M. Miller, and W. E. Woodward. 1975. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24:397-401.
11. Connelly, M., C. L. King, K. Bucci, S. Walters, B. Genton, M. P. Alpers, M. Hollingdale, and J. W. Kazura. 1997. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect. Immun. 65:5082-5087.
12. Ferreira, A., L. Schofield, V. Enea, H. Schellekens, P. Van der Meide, W. E. Collins, R. S. Nussenzweig, and V. Nussenzweig. 1986. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-IFN. Science 232:881-884.
13. Fidock, D. A., H. Grans-Masse, J. P. Lepers, K. Brahimi, L. BenMohammed, S. Mellouk, C. Guerin-Marchand, A. Lodono, L. Raharimalala, J. Meis, G. Langsley, C. Roussilhon, A. Tartar, and P. Druilhe. 1994. Plasmodium liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 153:190-204.
14. Good, M. F., D. Pombo, I. A. Quakyi, E. M. Riley, R. A. Houghten, A. Menon, D. W. Alling, J. A. Berzofsky, and L. H. Miller. 1988. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA 85:1199-1203.
15. Guerin-Marchand, C., P. Druilhe, B. Galey, A. Londono, J. Patarapotikul, R. L. Beaudoin, C. Dubeaux, A. Tartar, O. Mercerear-Puijalon, and G. Langsley. 1987. A liver-stage-specitic antigen of Plasmodium falciparum characterized by gene cloning. Nature 329:164-167.
16. Herrington, D., J. Davis, E. Nardin, M. Beier, J. Cortese, H. Eddy, G. Losonsky, M. Hollingdale, M. Sztein, M. Levin, R. S. Nussenzweig, D. Clyde, and R. Edelman. 1991. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am. J. Trop. Med. Hyg. 45:539-547.
17. Hill, A. V. S., J. Elvin, A. C. Willis, M. Aidoo, C. E. M. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. M. Townsend, A. J. McMichael, and H. C. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439.
18. Hill, A. V. S., C. E. M. Allsopp, D. Kwiatkowski, N. M. Anstey, T. Twumasi, P. A. Rowe, S. Bennett, D. Brewster, A. J. McMichael, and B. M. Greenwood. 1991. Common West African HLA antigens are associated with protection from severe malaria. Nature 352:595-600.
19. Hoffman, S. L., C. N. Oster, C. Mason, J. C. Bieir, J. A. Sherwood, W. R. Ballou, M. Mugambi, and J. D. Chulay. 1989. Human lymphocyte proliferative response to sporozoite T cell epitopes correlates with resistance to falciparum malaria. J. Immunol. 142:1299-1303.
20. Hollingdale, M. R., M. Aikawa, C. T. Atkinson, W. R. Ballou, G. Chen, J. Li, J. F. G. M. Meis, B. Sina, C. Wright, and J. Zhu. 1990. Non-CS preerythrocytic protective antigens. Immunol. Lett. 25:71-76.
21. Ignatowicz, L., W. Kees, R. Pacholczyk, H. Ignatowicz, E. Kushnir, J. Kappler, and P. Marrack. 1997. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 7:179-186.
22. Kabilan, L., V. P. Sharma, P. Kaur, S. K. Ghosh, R. S. Yadav, and V. S. Chauhan. 1994. Cellular and humoral immune responses to well defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic. Infect. Immun. 62:685-691.
23. Kaur, P., P. Sharma, A. Kumar, and V. S. Chauhan. 1990. Synthetic, immunological and structural studies on repeat unit peptides of Plasmodium falciparum antigens. Int. J. Pept. Protein Res. 36:515-521.
24. Krzych, U., J. A. Lyon, T. Jareed, I. Schneider, M. R. Hollingdale, D. M. Gordon, and W. R. Ballou. 1995. Lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155:4072-4081.
25. Margalit, H., J. L. Cournette, K. B. Cease, C. Delisi, and J. A. Berzofsky. 1987. Prediction of immunodominant T cell antigenic sites from the primary sequence. J. Immunol. 138:2213-2229.
26. Mellouk, S., F. Lunel, M. Sedegah, R. L. Beaudoin, and P. Druilhe. 1990. Protection against malaria induced by irradiated sporozoites. Lancet 335: 721.
27. Mellouk, S., R. K. Maheshwari. A. Rhodes-Feiuillette, R. L. Beaudoin, N. Berbiguier, H. Matile, F. Miltgen, I. Landeau, S. Pied, J. P. Chigot, R. M. Friedman, and D. J. Mazier. 1987. Inhibitory effects of IFNs and IL-1 on the development of Plasmodium falciparum in human hepatocyte cultures. J. Immunol. 139:4192-4195.
28. Nardin, E. H., and R. S. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:687-693.
29. National Institutes of Health. 1985. Guide for the care and use of laboratory animals. National Institutes of Health publication no. 86-23. U.S. Department of Health and Human Services, Washington, D.C.
30. Otoo, L. N., E. M. Riley, A. Menon, P. Byass, and B. M. Greenwood. 1989. Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. Trans. R. Soc. Trop. Med. Hyg. 83:778-782.
31. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237-2242.
32. Rieckmann, K. H., R. L. Beaudoin, J. S. Cassells, and K. W. Sell. 1979. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull. W. H. O. 57(Suppl.1):261-265.
33. Riley, E. M., C. MacLennan, D. K. Wiatkowski, and B. M. Greenwood. 1989. Suppression of in vitro lymphoproliferative responses in acute malaria patients can be partially reversed by indomethacin. Parasite Immunol. (Oxford) 11:509-517.
34. Romagnani, S., M. Kapsenberg, A. Radbruch, and L. Adorini. 1998. Th1 and Th2 cells. Res. Immunol. 149:871-873.
35. Sharma, P., A. Kumar, B. Singh, A. Bharadwaj, V. N. Sailaja, T. Adak, A. Kushwaha, P. Malhotra, and V. S. Chauhan. 1998. Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues. Infect. Immun. 66: 2895-2904.
36. Sina, B. J., V. E. Do Rosario, G. Woollett, K. Sakhuja, and M. R. Hollingdale. 1993. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection. Exp. Parasitol. 77:129-135.
37. Sinigaglia, F., M. Guttinger, J. Kilgus, D. M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Gillessen, and J. R. L. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336:778-780.
38. Troye-Blomberg, M., P. Romero, and M. E. Patarroyo. 1984. Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin. Exp. Immunol. 58:380-387.
39. Wahlin, B., A. Sjolander, N. Ahlborg, R. Udomsangpetch, A. Scherf, D. Mattei, K. Berzins, and P. Perlmann. 1992. Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro. Infect. Immun. 60:443-449.
40. White, K. L., D. L. Jarboe, and U. Krzych. 1994. Immunization with irradiated Plasmodium berghei sporozoites induces IL-2 and IFN-γ but not IL-4. Parasite Immunol. (Oxford) 16:479-491.
41. Windhagen, A., C. Scolz, P. Hollsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373-380.
42. World Health Organization. 1996. World Health Organization Fact Sheet N94 (revised). World Health Organization, Geneva, Switzerland.
43. Zhu, J., and M. R. Hollingdale. 1991. Structure of Plasmodium falciparum liver stage antigen-1. Mol. Biochem. Parasitol. 48:223-226.